Systemic treatment of locally advanced nonmetastatic cutaneous squamous cell carcinoma: A review of the literature

British Journal of Dermatology

Volumn 165, Issue 6, 2011, Pages 1169-1177

  Behshad, R ^a,b   Garcia Zuazaga, J ^a,b   Bordeaux, J S ^a,b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; BLEOMYCIN; BORTEZOMIB; CAPECITABINE; CARBOPLATIN; CETUXIMAB; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DASATINIB; DOXORUBICIN; ERLOTINIB; ETRETINATE; FLUOROURACIL; GEFITINIB; HYDROXYCHLOROQUINE; HYDROXYUREA; IMATINIB; ISOTRETINOIN; METHOTREXATE; MITOMYCIN; MITOMYCIN C; MITOXANTRONE; PACLITAXEL; PANITUMUMAB; PEPLEOMYCIN; SUNITINIB; VINCRISTINE;

ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; DRUG EFFICACY; DRUG RESPONSE; DRUG TARGETING; HUMAN; LUNG HEMORRHAGE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SECOND CANCER; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UROGENITAL TRACT CANCER; XERODERMA PIGMENTOSUM;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MOLECULAR TARGETED THERAPY; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 82255175715     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10524.x     Document Type: Review

References (44)

1. Miller DL, Weinstock MA,. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994; 30: 774-8. (Pubitemid 24157120)
2. Weinberg AS, Ogle CA, Shim EK,. Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg 2007; 33: 885-99. (Pubitemid 47106729)
3. Ebell MH, Siwek J, Weiss BD, et al. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. Am Fam Physician 2004; 69: 548-56. (Pubitemid 38176273)
4. Suen JK, Bressler L, Shord SS, et al. Cutaneous squamous cell carcinoma responding serially to single-agent cetuximab. Anticancer Drugs 2007; 18: 827-9. (Pubitemid 46975970)
5. Bauman JE, Eaton KD, Martins RG,. Treatment of recurrent squamous cell carcinoma of the skin with cetuximab. Arch Dermatol 2007; 143: 889-92. (Pubitemid 47076487)
6. Baltaci M, Fritsch P, Weber F, et al. Treatment with gefitinib (ZD 1839) in a patient with advanced cutaneous squamous cell carcinoma. Br J Dermatol 2005; 153: 234-6. (Pubitemid 41044572)
7. Kawakami Y, Nakamura K, Nishibu A, et al. Regression of cutaneous squamous cell carcinoma in a patient with chronic myeloid leukaemia on imatinib mesylate treatment. Acta Derm Venereol 2008; 88: 185-6. (Pubitemid 351507203)
8. Ramadan KM, McKenna KE, Morris TC,. Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma. Lancet Oncol 2006; 7: 958-9. (Pubitemid 44615957)
9. Lippman SM, Meyskens FL Jr,. Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. Ann Intern Med 1987; 107: 499-502.
10. Berretti B, Grupper CH,. Cutaneous neoplasia and etretinate. In: Retinoid Therapy (, Spitzy KH, Karrer K, eds). Lancaster: MTP, 1984; 187-95.
11. Toma S, Monteghirfo S, Tasso P, et al. Antiproliferative and synergistic effect of interferon alpha-2a, retinoids and their association in established human cancer cell lines. Cancer Lett 1994; 82: 209-16. (Pubitemid 24231988)
12. Lippman SM, Parkinson DR, Itri LM, et al. 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 1992; 84: 235-41.
13. Tantranond P, Balducci L, Karam F, et al. Alternative management of cutaneous squamous cell carcinoma in an elderly man: report of a case and review of the literature. J Am Geriatr Soc 1992; 40: 510-12.
14. Shin DM, Glisson BS, Khuri FR, et al. Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer. J Clin Oncol 2002; 20: 364-70. (Pubitemid 34072517)
15. Brewster AM, Lee JJ, Clayman GL, et al. Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma. J Clin Oncol 2007; 25: 1974-8. (Pubitemid 46972779)
16. Hoff PM, Ansari R, Batist G, et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol 2001; 19: 2282-92. (Pubitemid 32366981)
17. Lewis KG, Lewis MD, Robinson-Bostom L, Pan TD,. Inflammation of actinic keratoses during capecitabine therapy. Arch Dermatol 2004; 140: 367-8. (Pubitemid 38332497)
18. Cartei G, Cartei F, Interlandi G, et al. Oral 5-fluorouracil in squamous cell carcinoma of the skin in the aged. Am J Clin Oncol 2000; 23: 181-4.
19. Morita S, Okamoto I, Kobayashi K, et al. Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutations. Clin Cancer Res 2009; 15: 4493-8.
20. Wollina U, Hansel G, Koch A, Köstler E,. Oral capecitabine plus subcutaneous interferon alpha in advanced squamous cell carcinoma of the skin. J Cancer Res Clin Oncol 2005; 131: 300-4. (Pubitemid 40558545)
21. Endrizzi BT, Lee PK,. Management of carcinoma of the skin in solid organ transplant recipients with oral capecitabine. Dermatol Surg 2009; 35: 1567-72.
22. Phan R, Phan L, Ginsberg LE, et al. Durable response to chemotherapy for recurrent squamous cell carcinoma of the cheek with perineural spread. Arch Ophthalmol 2009; 127: 1074-5.
23. Khansur T, Kennedy A,. Cisplatin and 5-fluorouracil for advanced locoregional and metastatic squamous cell carcinoma of the skin. Cancer 1991; 67: 2030-2.
24. Merimsky O, Neudorfer M, Spitzer E, Chaitchik S,. Salvage cisplatin and adriamycin for advanced or recurrent basal or squamous cell carcinoma of the face. Anticancer Drugs 1992; 3: 481-4.
25. Denic S,. Preoperative treatment of advanced skin carcinoma with cisplatin and bleomycin. Am J Clin Oncol 1999; 22: 32-4. (Pubitemid 30261586)
26. Holoye PY, Byers RM, Gard DA, et al. Combination chemotherapy of head and neck cancer. Cancer 1978; 42: 1661-9. (Pubitemid 9053503)
27. Guthrie TH Jr, Porubsky ES,. Successful systemic chemotherapy of advanced squamous and basal cell carcinoma of the skin with cis-diamminedichloroplatinum III and doxorubicin. Laryngoscope 1982; 92: 1298-9. (Pubitemid 13245612)
28. Guthrie TH Jr, McElveen LJ, Porubsky ES, Harmon JD,. Cisplatin and doxorubicin. An effective chemotherapy combination in the treatment of advanced basal cell and squamous carcinoma of the skin. Cancer 1985; 55: 1629-32. (Pubitemid 15103904)
29. Guthrie T Jr, Porubsky E, Luxenberg M, et al. Cisplatin-based chemotherapy in advanced basal and squamous cell carcinomas of the skin: results in 28 patients including 13 patients receiving multimodality therapy. J Clin Oncol 1990; 8: 342-6. (Pubitemid 20056568)
30. Sadek H, Azli N, Wendling JL, et al. Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin. Cancer 1990; 66: 1692-6. (Pubitemid 20381201)
31. Loeffler JS, Larson DA, Clark JR, et al. Treatment of perineural metastasis from squamous carcinoma of the skin with aggressive combination chemotherapy and irradiation. J Surg Oncol 1985; 29: 181-3. (Pubitemid 15069852)
32. Fujisawa Y, Umebayashi Y, Ichikawa E, et al. Chemoradiation using low-dose cisplatin and 5-fluorouracil in locally advanced squamous cell carcinoma of the skin: a report of two cases. J Am Acad Dermatol 2006; 55: S81-5. (Pubitemid 44556878)
33. Kishi K, Matsunaka M, Sato M, et al. T1 and T2 lip cancer: a superselective method of facial arterial infusion therapy-preliminary experience. Radiology 1999; 213: 173-9. (Pubitemid 29470424)
34. Wu CF, Chen CM, Chen CH, et al. Continuous intraarterial infusion chemotherapy for early lip cancer. Oral Oncol 2007; 43: 825-30.
35. Ajani JA, Burgess MA,. Multiple squamous cell carcinoma treated with intra-arterial cisplatin in a patient with rheumatoid arthritis. Cancer Treat Rep 1982; 66: 1987-9.
36. Roseman JM, Tench D, Bryant LR,. The safe use of cisplatin in hyperthermic isolated limb perfusion systems. Cancer 1985; 56: 742-4. (Pubitemid 15228262)
37. Stephens FO, Harker GJ,. The use of intra-arterial chemotherapy for treatment of malignant skin neoplasms. Australas J Dermatol 1979; 20: 99-107. (Pubitemid 10068154)
38. Gorre ME, Ellwood-Yen K, Chiosis G, et al. BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90. Blood 2002; 100: 3041-4.
39. Leard LE, Cho BK, Jones KD, et al. Fatal diffuse alveolar damage in two lung transplant patients treated with cetuximab. J Heart Lung Transplant 2007; 26: 1340-4. (Pubitemid 350256993)
40. Roy L, Guilhot J, Martineau G, et al. Unexpected occurrence of second malignancies in patients treated with interferon followed by imatinib mesylate for chronic myelogenous leukemia. Leukemia 2005; 19: 1689-92. (Pubitemid 43090424)
41. Baskaynak G, Kreuzer KA, Schwarz M, et al. Squamous cutaneous epithelial cell carcinoma in two CML patients with progressive disease under imatinib treatment. Eur J Haematol 2003; 70: 231-4. (Pubitemid 36511317)
42. Scheithauer W, McKendrick J, Begbie S, et al. Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Ann Oncol 2003; 14: 1735-43. (Pubitemid 38029045)
43. Robbins KT, Storniolo AM, Kerber C, et al. Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies. Head Neck 1992; 14: 364-71.
44. Hirai T, Korogi Y, Hamatake S, et al. Stages III and IV squamous cell carcinoma of the mouth: three-year experience with superselective intraarterial chemotherapy using cisplatin prior to definitive treatment. Cardiovasc Intervent Radiol 1999; 22: 201-5. (Pubitemid 29269039)